Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Carasent AB ( (SE:CARA) ).
Carasent AB, a Swedish healthcare technology company providing digital solutions to healthcare providers, will publish its interim report for the fourth quarter of 2025 on 12 February 2026 at 07:00 CET. The business focuses on software and digital platforms that streamline clinical and administrative work for healthcare professionals.
On the same day, Carasent will host a webcast presentation of the Q4 results at 08:00 CET, complemented by a teleconference option for participants who wish to ask questions verbally. The scheduled presentation underscores the company’s effort to maintain transparent communication with investors and other stakeholders around its financial performance and operational progress.
The most recent analyst rating on (SE:CARA) stock is a Hold with a SEK26.00 price target. To see the full list of analyst forecasts on Carasent AB stock, see the SE:CARA Stock Forecast page.
More about Carasent AB
Carasent AB is a Swedish public company in the healthcare technology and digital services space, focusing on delivering software and digital solutions to healthcare providers. The company targets professional users in the Nordic market and beyond, supporting clinical workflows and administrative processes through its digital platforms and related services.
Average Trading Volume: 114,879
Technical Sentiment Signal: Buy
Current Market Cap: SEK1.65B
For detailed information about CARA stock, go to TipRanks’ Stock Analysis page.